Genome engineering with Type I CRISPR systems in eukaryotic cells Grant US-11905526-B2 United States of America 20 Feb 2024
THERAPEUTIC TARGETS FOR THE CORRECTION OF THE HUMAN DYSTROPHIN GENE BY GENE EDITING AND… Application EP-3384055-A4 European Patent Office 17 Apr 2019